World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Feb 16
Smoking ban 'cuts premature births
The theory that public smoking bans cut the number of children born prematurely has been strengthened by new research.

The study of 600,000 births found three successive drops in babies born before 37 weeks - each occurring after a phase of a public smoking ban was introduced.

There was no such trend in the period before the bans were put in place, the British Medical Journal reported.

The study, by Hasselt University in Belgium, comes after Scottish research in 2012 found a similar pattern.

But experts could not fully state the smoking ban was the cause of the change because pre-term births had started to drop before the ban.

It is already well established that smoking leads to reduced birth weight and an increased risk of premature birth.
Successive drops

In the latest study researchers were able to look at the rate of premature births after each phase of a smoking ban came into force in Belgium.

Public places and most workplaces were first to introduce smoke-free rules in 2006, followed by restaurants in 2007 and bars serving food in 2010.

The rate of premature births was found to fall after each phase of the ban with the biggest impact seen after the second two bans with restaurants and bars introducing no smoking rules.

After the bans in 2007 and 2010, the premature birth rate dropped by around 3% each time.

Overall it corresponds to a fall of six premature babies in every 1,000 births.

The changes could not be explained by other factors - such as mother's age and socioeconomic status or population effects such as changes in air pollution and influenza epidemics.

There was no link found with birth weight.

Study leader Dr Tim Nawrot from Hasselt University said that even a mild reduction in gestational age has been linked in other studies to adverse health outcomes in early and later life.

"Because the ban happened at three different moments, we could show there was a consistent pattern of reduction in the risk of preterm delivery."

He added: "It supports the notion that smoking bans have public health benefits even from early life."

Patrick O'Brien, spokesperson for the Royal College of Obstetricians and Gynaecologists said: "It is very gratifying to see further strong evidence that smoking bans have had a beneficial impact on pregnant women and their babies."

Feb 16
HIV increase in gay men caused by fall in condom use
A modest increase in unprotected sex is enough to erode the benefits of other interventions, researchers said

A fall in the proportion of gay and bisexual men using condoms is behind the rise in HIV infections in those groups in the UK, say researchers.

Wider use of anti-retroviral drugs has helped to stop a sharper rise, a study by the Health Protection Agency (HPA) and a number of universities found.

They found a 26% rise, from 1990-2010, in the proportion of men who have sex with men who did not use condoms.

The report said the figures showed it was vital to promote safe sex.

Rates of HIV have been rising in recent years with latest figures showing cases among men who have sex with men (MSM) in the UK reaching an all-time high.

A recent report from the HPA found that nearly half of the 6,280 people diagnosed in the UK in 2011 were MSM.

Overall, one in 20 MSM are infected with HIV.

For this study, researchers analysed data from 1990 to 2010. They concluded that, without the introduction of anti-retroviral drugs to treat those with HIV, infections would be 68% higher in MSM.

Therapy with anti-retrovirals lowers the risk of people with HIV infecting others.

The report suggested the incidence of HIV could be 32% lower if all anti-retroviral treatment were prescribed from the moment of diagnosis rather than when health declined.
Informed choices

Further analysis showed that, if all MSM had stopped using condoms from 2000, rates of HIV in this group would now be 400% higher, the journal PLoS One reported.

The data also showed that the incidence of HIV could have dropped by a quarter if more HIV testing had been done.

But the researchers said the results showed that even a modest increase in unprotected sex was enough to erode the benefits of other interventions.

Study leader Professor Andrew Phillips, from University College London, said: "By better understanding the driving forces behind the trends we've seen in the past, it will allow us to make informed choices to reduce new HIV infections in the future."

Co-author Dr Valerie Delpech, who is head of HIV surveillance at the HPA, said: "Everyone should use a condom when having sex with new or casual partners, until all partners have had a sexual health screen.

"We also encourage men who have sex with men to get an HIV and STI screen at least annually, and every three months if having condomless sex with new or casual partners - and clinicians to take every opportunity to recommend HIV testing to this group."

Sir Nick Partridge, chief executive of the Terrence Higgins Trust, said condom use by gay men had played a key part in containing the spread of HIV in the UK.

"Without it, there would have been 80,000 more gay men with HIV between 2000 and 2010."

He added that the study showed the impact of the combined HIV strategy of promoting condoms, increasing regular HIV testing and encouraging the earlier use of anti-HIV drug therapy.

He added: "At a time when funding for local HIV prevention programmes is under threat, this only reinforces the important role which local authorities can and must play in funding local HIV prevention."

Feb 15
New potential drug target for cancer identified
Scientists have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

Additionally, the international team led by scientists at The University of Texas MD Anderson Cancer Center found the cancer drug sunitinib potentially has a new role in treating triple-negative, claudin-low breast cancer, a particularly resistant version of a type of cancer that is already difficult to treat.

"We found that FOXC2 lies at the crossroads of the cellular properties of cancer stem cells and cells that have undergone epithelial to mesenchymal transition (EMT), a process of cellular change associated with generating cancer stem cells," said senior author Sendurai Mani, Ph.D., assistant professor in MD Anderson`s Department of Translational Molecular Pathology and co-director of the Metastasis Research Center.
Cancer stem cells are fewer in number than other tumor cells, yet research has tied them to cancer progression and resistance to treatment. Abnormal activation of the epithelial to mesenchymal transition can create cancer stem cells, Mani noted.

"There are multiple molecular pathways that activate EMT. We found many of these pathways also activate FOXC2 expression to launch this transition, making FOXC2 a potentially efficient check point to block EMT from occurring," Mani said.

Research uncovering this connection focused on cell line and mouse model experiments. The next important step will be to assess the expression and activity of FOXC2 in human tumor samples, he said.

In the meantime, sunitinib, known commercially as Sutent and approved by the U.S. Food and Drug Administration for three other cancers, provides interesting, more immediate, potential.

"FOXC2 is a transcription factor, a protein that binds to DNA in the promoter region of genes to activate them. For a variety of reasons, transcription factors are hard to target with drugs," Mani said.

The team found that FOXC2 also regulates the platelet derived growth factor receptor (PDGFR-Beta). In cancer cell lines, they found that the PDGFR-Beta inhibitor sunitinib inhibited growth of cells with EMT or cancer stem cell properties that have active FOXC2.

Mice with triple-negative breast cancer treated with sunitinib had smaller primary tumors, longer survival, and fewer incidences of metastasis. There also was a steep drop in the cells` ability to form mammospheres, a hallmark of cancer stem cells.

Mani said the team believes that targeting FOXC2 pathway using either PDGFR-beta inhibitors or other yet-to-be-known small-molecule inhibitors will be an effective therapeutic strategy for inhibiting EMT and consequently reducing EMT/cancer stem cell-associated metastasis, relapse and therapy resistance.

The study has been published in the journal Cancer Research.

Feb 15
Losing hope of good night`s sleep may lead to suicide
When people lose hope that they will ever get another good night`s sleep, they become at high risk for suicide, according to researchers.

Insomnia and nightmares, which are often confused and may go hand-in-hand, are known risk factors for suicide but just how they contribute was unknown, said Dr. W. Vaughn McCall, Chair of the Medical College of Georgia Department of Psychiatry and Health Behavior at Georgia Regents University.

The new study reaffirms that link and adds the element of hopelessness about sleep that is independent of other types of hopelessness, such as those regarding personal relationships and careers, said McCall, corresponding author of the study.

"It turns out insomnia can lead to a very specific type of hopelessness and hopelessness by itself is a powerful predictor of suicide," he said.

If the findings hold true in larger studies, they wave a red flag about suicide risk and point toward prevention that targets the negative thoughts with pharmaceuticals and psychological intervention.

The finding also is a reminder to physicians that depressed patients who report increased sleep problems should be asked if they are having suicidal thoughts, McCall said.

The scientists used psychometric testing to objectively assess the mental state of 50 depressed patients age 20-80 being treated as an inpatient, outpatient or in the Emergency Department. More than half had attempted suicide and most were taking an anti-depressant. Testing enabled the researchers to filter out other suicide risks such as depression itself and hone in on the relationship between insomnia and suicide risk, asking specific questions about dysfunctional beliefs about sleep such as: Do you think you will ever sleep again?
"It was this dysfunctional thinking, all these negative thoughts about sleep that was the mediating factor that explained why insomnia was linked to suicide," said McCall, who specializes in depression and sleep disorders.

The likelihood of being suicidal at least doubles with insomnia as a symptom, McCall noted.

The finding appeared in Journal of Clinical Sleep Medicine , the journal of the American Academy of Sleep Medicine.

Feb 14
High calcium intake may up risk of heart disease in women
Women with high calcium intake are at a greater risk of cardiovascular disease, a new study has claimed.

Researchers from Uppsala University in Sweden studied 61,443 Swedish women (born between 1914 and 1948) for an average of 19 years to test an association between high calcium intake and risk of ischemic heart disease and stroke.
Data were taken from the Swedish Cause of Death Registry and data on diet were taken from the Swedish Mammography Cohort.

Total calcium intake included supplemental calcium. The average intake in the lowest quartile was 572 mg per day (the equivalent of five slices of cheese) and in the highest 2137 mg per day.

Results showed that during 19 years of follow-up, 11,944 women (17 per cent) died: 3,862 of these (32 per cent) died from cardiovascular disease, 1932 (16 per cent) heart disease and 1100 (8 per cent) from stroke.

Highest rates of all-cause, cardiovascular and heart disease were observed among those with a dietary calcium intake higher than 1400 mg per day, journal bmj.Com reported.

In addition, researchers observed higher death rates among women with an intake below 600 mg per day.

Women who had a higher dietary intake of calcium exceeding 1400 mg per day and also used supplements had a higher death rate compared to those not taking supplements.

Women with a high dietary calcium intake (more than 1400 mg per day) were more than twice as likely to die compared with women with a 600 to 999 mg per day calcium intake.

The researchers suggested that diets very low or very high in calcium can override normal homeostatic control causing changes in blood levels of calcium.

The researchers concluded that high calcium is associated with "higher all-cause and cardiovascular mortality rates" and so to prevent fractures in the elderly emphasis should be placed on individuals with a low intake of calcium rather than increasing the intake of those already consuming satisfactory amounts.

Feb 14
First-born children prone to increased risk of diabetes
Birth order may raise the risk of first-born children developing diabetes or high blood pressure, a study has claimed.

It found that first-born children have greater difficulty absorbing sugars into the body and have higher daytime blood pressure than children who have older siblings.

The study conducted at the University of Auckland's Liggins Institute in New Zealand, measured fasting lipid and hormonal profiles, height, weight and body composition in 85 healthy kids between the ages of 4 and 11.
The 32 first-born children, who participated in the study had a 21 percent reduction in insulin sensitivity and a 4 mmHg increase in blood pressure.

The study found that the oldest and only children tended to be taller and slimmer than their later-born counterparts, even after the height and body mass index of their parents was taken into account.

The metabolic differences in younger siblings could be caused by physical changes in the mother's uterus during her first pregnancy. As a result of the changes, nutrient flow to the foetus tends to increase during subsequent pregnancies.

For this study, researchers focused on kids as puberty and adult lifestyle could affect insulin sensitivity.

The study will be published in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM).

Feb 13
Relationship anxiety could weaken immune system
Anxieties and concerns and about one's close relationships could prove to be a chronic stressor that can compromise immunity, a new study has found.

In the study, researchers asked married couples to complete questionnaires about their relationships and collected saliva and blood samples to test participants levels of a key stress-related hormone and numbers of certain immune cells.

The research focused on attachment anxiety. Those who are on the high end of the attachment anxiety spectrum are excessively concerned about being rejected, have a tendency to constantly seek reassurance that they are loved, and are more likely to interpret ambiguous events in a relationship as negative.

Married partners who were more anxiously attached produced higher levels of cortisol, a steroid hormone that is released in response to stress, and had fewer T cells important components of the immune system's defense against infection than did participants who were less anxiously attached.

"Everyone has these types of concerns now and again in their relationships, but a high level of attachment anxiety refers to people who have these worries fairly constantly in most of their relationships," Lisa Jaremka, lead author of the study and a postdoctoral fellow in Ohio State University's Institute for Behavioral Medicine Research (IBMR) said.

Though some scientists theorize that attachment anxiety can be traced to inconsistent care during one's infancy, Jaremka noted that there is also research-based evidence that people with attachment anxiety can change.

The study is set to be published in the journal Psychological Science.

Feb 13
Caloric restriction, exercise help prevent pregnancy complications
Consistent physical activity and healthier lifestyle changes beginning in a woman`s first trimester can prevent excessive weight gain in obese pregnant women, helping to avoid preterm delivery, hypertension and gestational diabetes, suggests a new study.

This randomized study may help physicians understand why it is important to offer more specific advice to obese women who are pregnant regarding the amount of weight they should gain during their pregnancy.

"Weight gain should be monitored related closely to the starting weight. If you start with normal BMI [defined by weight before pregnancy divided by height measured in squared meters] could increase 11-16 kilograms. But if you are obese, the expectation is that you should only gain 5-9 kilos-more or less just the weight of the pregnancy" said Dr. Fabio Facchinetti, referencing the Institute of Medicine (IOM) in the United States.

Researchers from the University of Modena and Reggio Emilia`s mother-infant department teamed up with their colleagues in the clinical diagnostic medicine and public health department to create a Therapeutic Lifestyle Changes (TLC) Program.

The 33 women in the treatment group followed a regimen of 1500 kcal/day diet coupled with mild physical activity (30 minutes/day, 3 times/week). Twenty-eight women in the control group just received general advice from their OB/GYN. They only worked with single pregnancies and treatment began at 12 weeks.

Their research shows that of the obese subgroup of women [those in TLC group with BMI less than 30] who stuck with a proper diet and exercise, 77.8 percent were able to stay within the allotted weight gain limit, as opposed to only 30 percent from the control group. Additionally, the rate of, hypertension, preterm delivery and gestational diabetes was significantly lower in the TLC group.

"The diagnosis of gestational diabetes is done [by having the women drink] 75 grams of glucose and looking at the levels after one and two hours," said Facchinetti.

"In our study, we found [after monitoring the glucose levels] that 57 percent of obese women in the non-treatment group had diabetes whereas in the treatment group, it was only 21 percent. This is important because [the glucose test] was done at 16-18 weeks and, even if negative, repeated at 24 weeks. In other words, if the first evaluation occurred just 12 weeks after the treatment began, the small amount of time was enough to correct the body`s level of glucose," he added.

The study will be presented on February 15 at the Society for Maternal-Fetal Medicine`s annual meeting, The Pregnancy Meeting, in San Francisco.

Feb 12
Study finds obesity can 'lead to lack of vitamin D'
Obesity can lower vitamin D levels in the body, a study suggests.

The report, in the journal PLOS Medicine, analysed genetic data from 21 studies - a total of 42,000 people.

It found every 10% rise in body mass index (BMI) - used as an indicator of body fat - led to a 4% drop of available vitamin D in the body.

As vitamin D is stored in fatty tissue, the authors suggest the larger storage capacity in obese people may prevent it from circulating in the bloodstream.

BMI it is calculated by taking weight (in kilograms) and dividing it by height (in metres) squared. Those with a BMI of 30 or above are considered obese.

Lead author Dr Elina Hypponen, from the University College London Institute of Child Health, said the study "highlights the importance of monitoring and treating vitamin D deficiency in people who are overweight or obese".

Vitamin D is made in the skin after sun exposure and can be taken in dietary supplements.

Healthy levels are about 50 nanomole per litre - less than 30 nanomole per litre can cause the softening and weakening of bones, leading to rickets in children and osteomalacia in adults.

Prof David Haslam, from the National Obesity Forum, said: "Food intake and genetics all play a part in obesity - but this research is a reminder that physical activity, like walking the dog or going for a run out in the sunshine, shouldn't be forgotten and can help correct both weight and lack of vitamin D."

Feb 12
Skin 'may restore' diseased MS brain
It may be possible to use a patient's own skin to repair the damage caused by multiple sclerosis (MS), which is currently incurable, say researchers.

Nerves struggle to communicate in MS as their insulating covering is attacked by the immune system - causing fatigue and damaging movement.

Animal tests, described in the journal Cell Stem Cell, have now used modified skin cells to repair the insulation.

Experts said there was an "urgent need" for such therapies.

Just like electrical wires, nerves have insulation - but instead of plastic, the body uses a protein called myelin.

However, diseases that result in damage to the myelin, including MS, leave the nerves exposed and electrical signals struggle to travel round the body.
Stem cells

A team of scientists at the University of Rochester Medical Center, in the US, used advances in stem-cell research to attempt to repair the myelin.

They took a sample of human skin cells and converted it into stem cells, which are capable of becoming any other type of cell in the body.

The next step was to transform the stem cells into immature versions of cells in the brain that produce myelin.

When these cells had been injected into mice born without any myelin it had had a significant effect, said researchers.

Dr Steven Goldman told the BBC that "myelin was produced throughout the nervous system" and some mice had achieved "normal life spans".

He said: "In MS the underlying nerves fibres are still there, the objective is to re-myelinate them."

However, MS patients would still have the problem of their immune system attacking their myelin.

Any treatment would need to be used alongside other therapies to tame the immune system - or would need to be repeatedly performed.

Dr Goldman said he could see "no reason to be pessimistic" although further safety tests would be needed and the technique still needed to be refined before being used in people. He expects to begin trials within a couple of years.

Dr Emma Gray, from the MS Society, said: "Myelin repair therapies are urgently needed in MS and we're pleased to see researchers have been able to generate myelin making cells from human stem cells.

"This is still very early stage research, but with more development could one day be used to repair damage to myelin in people with MS. We look forward to seeing more research in this promising area."

Browse Archive